Michael Luís
Michael Luís publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Public Health, Environmental and Occupational Health, on topics such as Lung Cancer Treatments and Mutations, Palliative Care and End-of-Life Issues and Cancer, Hypoxia, and Metabolism.
- World rank
- #5,071,122 of 7,710,434 ranked researchers
- Rank in Portugal
- #26,276 of 41,760
- Works
- 17
- Citations
- 66
- Citations per work
- 3.9
What does Michael Luís research?
Michael Luís's work is mostly in Medicine (56%), Biochemistry, Genetics and Molecular Biology (6%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1056.5%
- Medicine1056.5%
- Everything else637.0%
- Life Sciences16.5%
- 1Pulmonary and Respiratory Medicine17% of their works
- 2Oncology15% of their works
- 3Public Health, Environmental and Occupational Health9% of their works
- 4Surgery9% of their works
- 5Hematology6% of their works
- 6Cancer Research6% of their works
Research topics
- Lung Cancer Treatments and Mutations
- Palliative Care and End-of-Life Issues
- Cancer, Hypoxia, and Metabolism
- Central Venous Catheters and Hemodialysis
- Erythropoietin and Anemia Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Venous Thromboembolism Diagnosis and Management
- Gastric Cancer Management and Outcomes
Which keywords describe Michael Luís's research?
The keywords of their largest research topics: Clinical Practice Guidelines, Diagnosis, EGFR Mutations, Targeted Therapy, Treatment, End-of-Life, Palliative Care and Anemia.
- Venous Thromboembolism
- Hepatocellular Carcinoma
- Gastric Cancer
- Chemotherapy
- Catheter-Related Infections
- Anemia
- End-of-Life
- Targeted Therapy
- Diagnosis
- Clinical Practice Guidelines
- EGFR Mutations
- Treatment
- Palliative Care
- Antithrombotic Therapy
- Central Venous Catheterization
- Chronic Kidney Disease
- HIF-1
- Liver Cancer
- Warburg Effect
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 19 words, with their numbers
- Clinical Practice Guidelines63 topics
- Diagnosis42 topics
- EGFR Mutations41 topic
- Targeted Therapy41 topic
- Treatment42 topics
- End-of-Life31 topic
- Palliative Care31 topic
- Anemia21 topic
- Antithrombotic Therapy21 topic
- Catheter-Related Infections21 topic
- Central Venous Catheterization21 topic
- Chemotherapy21 topic
- Chronic Kidney Disease21 topic
- Gastric Cancer21 topic
- HIF-121 topic
- Hepatocellular Carcinoma21 topic
- Liver Cancer21 topic
- Venous Thromboembolism21 topic
- Warburg Effect21 topic
Where does Michael Luís work?
Michael Luís's main affiliation in the publication record is IPO Porto, Portugal.
How many publications and citations does Michael Luís have?
OpenAlex counts 17 works and 66 citations for Michael Luís, an h-index of 4, ranking #5,071,122 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Michael Luís. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.